Switching from originator-infliximab to biosimilar-Infliximab in IBD-patients does not lead to significant changes in infliximab trough levels

: Eberl A, Huoponen S, Pahikkala T, Arkkila P, Blom M, Sipponen T

Publisher: OXFORD UNIV PRESS

: 2017

 Journal of Crohn's and Colitis

: JOURNAL OF CROHNS & COLITIS

: J CROHNS COLITIS

: 11

: S406

: S407

: 2

: 1873-9946